Citation Impact
Citing Papers
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.
2006
Breast cancer
2019 Standout
Basal cell carcinomas: attack of the hedgehog
2008 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Single nucleotide polymorphism seeking long term association with complex disease
2002
Prognostic Factors in Non-small Cell Lung Cancer
2002
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
2011
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
2000
The 2004 World Health Organization classification of lung tumors
2005 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
The human keratins: biology and pathology
2008 Standout
Convolutional neural networks: an overview and application in radiology
2018 Standout
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer
2001
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
2007
Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing
2005
Machine learning applications in cancer prognosis and prediction
2014 Standout
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
2007 Standout
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
2007
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
2012 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Cytokeratin Markers Come of Age
2007
Clinical utility of cytokeratins as tumor markers
2004
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Recent Advances in Breast Cancer Genetics
2007
Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer Patients
1998
The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round
2009
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
2006
Lipoprotein Genotype and Conserved Pathway for Exceptional Longevity in Humans
2006
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer
1999
Cancer of the Ovary
2004 Standout
Racial differences in genetic factors associated with breast cancer
2003
BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.
2000
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis.
2002 StandoutNobel
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Application of Breast Cancer Risk Prediction Models in Clinical Practice
2003
Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer
2012
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
Nanostructures in Biodiagnostics
2005 Standout
Works of Norman Heching being referenced
Cytokeratin Markers in Malignant Pleural Mesothelioma
1998
Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma
1998
Computed Tomography Screening for Lung Cancer: Applicability of an International Protocol in a Single-Institution Environment
2006
The Prognostic Significance of Circulating Neuroendocrine Markers Chromogranin A, Pro-Gastrin-Releasing Peptide and Neuron-Specific Enolase in Patients with Advanced Non-Small-Cell Lung Cancer
2005
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
2000
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
1997